New Notions of Reduction and Non-Semantic Proofs of β-Strong Normalization in Typed λ-Calculi

Two new notions of reduction for terms of the λ-calculus are introduced and the question of whether a λ-term is beta-strongly normalizing is reduced to the question of whether a λ-term is merely normalizing under one of the new notions of reduction. This leads to a new way to prove beta-strong normalization for typed λ-calculi. Instead of the usual semantic proof style based on Girard's "candidats de réductibilité'', termination can be proved using a decreasing metric over a well-founded ordering in a style more common in the field of term rewriting. This new proof method is applied to the simply-typed λ-calculus and the system of intersection types.

Addendum to "New Notions of Reduction and Non-Semantic Proofs of β-Strong Normalization in Typed λ-Calculi"

This is an addendum to our technical report BUCS TR-94-014 of December 19, 1994. It clarifies some statements, adds information on some related research, includes a comparison with research be de Groote, and fixes two minor mistakes in a proof.

Neuropeptide Co-Release with Gaba May Explain Functional Non-Monotonic Uncertainty Responses in Dopamine Neurons

Co-release of the inhibitory neurotransmitter GABA and the neuropeptide substance-P (SP) from single axons is a conspicuous feature of the basal ganglia, yet its computational role, if any, has not been resolved. In a new learning model, co-release of GABA and SP from axons of striatal projection neurons emerges as a highly efficient way to compute the uncertainty responses that are exhibited by dopamine (DA) neurons when animals adapt to probabilistic contingencies between rewards and the stimuli that predict their delivery. Such uncertainty-related dopamine release appears to be an adaptive phenotype, because it promotes behavioral switching at opportune times. Understanding the computational linkages between SP and DA in the basal ganglia is important, because Huntington's disease is characterized by massive SP depletion, whereas Parkinson's disease is characterized by massive DA depletion.